Dec 24 (Reuters) - Shares of Agios Pharmaceuticals (AGIO) jumped 18% on Wednesday after the U.S. Food and Drug Administration approved the expanded use of its drug for the treatment of a type of blood disorder.
The drug mitapivat is now approved as a treatment for patients with anemia in both non-transfusion-dependent and transfusion-dependent alpha- or beta-thalassemia, the company said late on Tuesday.
Thalassemia is an inherited blood disorder affecting the body's ability to produce hemoglobin and healthy red blood cells.
The drug, under the brand name Aqvesme, is expected to be available in late January next year, following the implementation of the required safety program.
Mitapivat was already approved by the U.S. FDA in 2022 to treat low red blood cell counts in adults with pyruvate kinase deficiency, under the brand name of Pyrukynd.
"The approval unlocks an additional $320 million in peak revenue opportunity layered atop the existing mitapivat franchise," Truist analyst Gregory Renza said.
The latest approval is based on a late-stage study in which patients receiving mitapivat showed a statistically significant increase in hemoglobin response compared to those on placebo.
Aqvesme will carry a boxed warning for liver function tests every four weeks during the first 24 weeks of treatment and advises against use in patients with cirrhosis, Renza added.
(Reporting by Siddhi Mahatole in Bengaluru; Editing by Vijay Kishore)
LATEST POSTS
- 1
Kate Middleton and Prince William unveil annual family Christmas card photo with George, Charlotte and Louis - 2SUVs Known for Their Looks As opposed to Their Capacity
- 3Really focusing on Succulents: Tips and Procedures
- 4Wedding trip Objections in Europe
- 5Damaged Shenzhou-20 spacecraft to return to Earth uncrewed for inspection
- African nations push to recognize crimes of colonialism in Algeria
- Mystery foot suggests a second early human relative lived alongside Lucy
- Europe could get 42 more days of summer by the year 2100 due to climate change
- Putin, Netanyahu discuss Middle East in phone call, Kremlin says
- Miss 'Stranger Things' already? Here's how you can get your Upside Down fix in 2026 with spinoffs, games and more
- Fundamental Venture The board Apparatuses for Remote Groups
- 6 Well known Ladies' Fragrances On the planet
- UN torture cm'tee report flags Israel for allegedly mistreating journalists, detainees, ex-MAG
- What to know about voluntary chocolate recall
